Arbutus Biopharma
ABUS
#7051
Rank
A$0.93 B
Marketcap
A$6.07
Share price
-1.23%
Change (1 day)
-8.99%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2026 (TTM): A$1.18

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is A$1.24. In 2025 the company made an earnings per share (EPS) of A-$0.26 an increase over its 2024 EPS that were of A-$0.57.

EPS history for Arbutus Biopharma from 1998 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$1.18-560.56%
2025A-$0.26-55.26%
2024A-$0.57-13.64%
2023A-$0.66-4.35%
2022A-$0.69-44.58%
2021A-$1.25-17%
2020A-$1.51-65.4%
2019A-$4.37138.84%
2018A-$1.83-22.44%
2017A-$2.36-78.45%
2016A-$10.94424.64%
2015A-$2.08-20.19%
2014A-$2.6187.96%
2013A-$1.39-142.59%
2012A$3.26-342.7%
2011A-$1.34-25.82%
2010A-$1.8147.8%
2009A-$1.23-43.55%
2008A-$2.17158.91%
2007A-$0.84-111.88%
2006A$7.06-552.53%
2005A-$1.56-71.77%
2004A-$5.53-14.48%
2003A-$6.47-8.95%
2002A-$7.1070.07%
2001A-$4.1848.01%
2000A-$2.82-38.54%
1999A-$4.59-24.6%
1998A-$6.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
A-$0.09065-107.32% Bahamas
NRC Health
NRC
A$0.44-64.63%๐Ÿ‡บ๐Ÿ‡ธ USA